Rechallenging with PD-1 Inhibitors: Incidence and Management of Immune-Related Adverse Events in Metastatic NSCLC-MedSci.cn - 梅斯（MedSci）

Rechallenging with PD-1 Inhibitors: Incidence and Management of Immune-Related Adverse Events in Metastatic NSCLC

Hoang, T; Elliot, MJ; Poletes, C; Corke, L; Weiss, J; Tsao, MS; Bradbury, P; Shepherd, FA; Liu, G; Leighl, N; Sacher, A; Lau, SCM

JOURNAL OF THORACIC ONCOLOGY, 2022; 17 (9): S372

科室
- - 订阅+
  - 更多科室
工具
服务